Antigen specificity determines anti-red blood cell IgG-Fc alloantibody glycosylation and thereby severity of haemolytic disease of the fetus and newborn. (Q50222648)

From Wikidata

Jump to navigation Jump to search

scientific article published on 28 November 2016

Language	Label	Description	Also known as
English	Antigen specificity determines anti-red blood cell IgG-Fc alloantibody glycosylation and thereby severity of haemolytic disease of the fetus and newborn.	scientific article published on 28 November 2016

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

27 February 2018

http://europepmc.org/abstract/MED/27891581

Antigen specificity determines anti-red blood cell IgG-Fc alloantibody glycosylation and thereby severity of haemolytic disease of the fetus and newborn. (English)

1 reference

Europe PubMed Central

PubMed publication ID

27 February 2018

http://europepmc.org/abstract/MED/27891581

1 reference

based on heuristic

inferred from title

Gestur Vidarsson

11

1 reference

Europe PubMed Central

PubMed publication ID

27 February 2018

http://europepmc.org/abstract/MED/27891581

Ellen van der Schoot

10

object named as

C Ellen van der Schoot

1 reference

Europe PubMed Central

PubMed publication ID

27 February 2018

3

object named as

Masja de Haas

1 reference

Europe PubMed Central

PubMed publication ID

27 February 2018

author name string

Myrthe E Sonneveld

1

1 reference

Europe PubMed Central

PubMed publication ID

27 February 2018

http://europepmc.org/abstract/MED/27891581

Joke Koelewijn

2

1 reference

Europe PubMed Central

PubMed publication ID

27 February 2018

http://europepmc.org/abstract/MED/27891581

Jon Admiraal

4

1 reference

Europe PubMed Central

PubMed publication ID

27 February 2018

http://europepmc.org/abstract/MED/27891581

Rosina Plomp

5

1 reference

Europe PubMed Central

PubMed publication ID

27 February 2018

http://europepmc.org/abstract/MED/27891581

Carolien A M Koeleman

6

1 reference

Europe PubMed Central

PubMed publication ID

27 February 2018

http://europepmc.org/abstract/MED/27891581

Agnes L Hipgrave Ederveen

7

1 reference

Europe PubMed Central

PubMed publication ID

27 February 2018

http://europepmc.org/abstract/MED/27891581

Peter Ligthart

8

1 reference

Europe PubMed Central

PubMed publication ID

27 February 2018

http://europepmc.org/abstract/MED/27891581

Manfred Wuhrer

9

1 reference

Europe PubMed Central

PubMed publication ID

27 February 2018

http://europepmc.org/abstract/MED/27891581

language of work or name

0 references

publication date

28 November 2016

1 reference

Europe PubMed Central

PubMed publication ID

27 February 2018

http://europepmc.org/abstract/MED/27891581

British Journal of Haematology

1 reference

Europe PubMed Central

PubMed publication ID

27 February 2018

http://europepmc.org/abstract/MED/27891581

176

1 reference

Europe PubMed Central

PubMed publication ID

27 February 2018

http://europepmc.org/abstract/MED/27891581

4

1 reference

Europe PubMed Central

PubMed publication ID

27 February 2018

http://europepmc.org/abstract/MED/27891581

651-660

1 reference

Europe PubMed Central

PubMed publication ID

27 February 2018

http://europepmc.org/abstract/MED/27891581

Natural variation in Fc glycosylation of HIV-specific antibodies impacts antiviral activity

1 reference

https://api.crossref.org/works/10.1111%2FBJH.14438

21 January 2018

The role of differential IgG glycosylation in the interaction of antibodies with FcγRs in vivo

1 reference

https://api.crossref.org/works/10.1111%2FBJH.14438

21 January 2018

Chemo-Enzymatic Synthesis of (13)C Labeled Complex N-Glycans As Internal Standards for the Absolute Glycan Quantification by Mass Spectrometry.

1 reference

https://api.crossref.org/works/10.1111%2FBJH.14438

21 January 2018

Comparison of the Fc glycosylation of fetal and maternal immunoglobulin G

1 reference

https://api.crossref.org/works/10.1111%2FBJH.14438

21 January 2018

Unique carbohydrate-carbohydrate interactions are required for high affinity binding between Fc RIII and antibodies lacking core fucose

1 reference

https://api.crossref.org/works/10.1111%2FBJH.14438

21 January 2018

IgG Fc N-glycosylation in Guillain-Barré syndrome treated with immunoglobulins

1 reference

https://api.crossref.org/works/10.1111%2FBJH.14438

21 January 2018

The prevalence of anti-K in Canadian prenatal patients

1 reference

https://api.crossref.org/works/10.1111%2FBJH.14438

21 January 2018

Haemolytic disease of the fetus and newborn

1 reference

https://api.crossref.org/works/10.1111%2FBJH.14438

21 January 2018

Post-translational modifications differentially affect IgG1 conformation and receptor binding.

1 reference

https://api.crossref.org/works/10.1111%2FBJH.14438

21 January 2018

Comparative performance of four methods for high-throughput glycosylation analysis of immunoglobulin G in genetic and epidemiological research

1 reference

https://api.crossref.org/works/10.1111%2FBJH.14438

21 January 2018

Implementation of routine screening for Kell antibodies: does it improve perinatal survival?

1 reference

https://api.crossref.org/works/10.1111%2FBJH.14438

21 January 2018

Low anti-RhD IgG-Fc-fucosylation in pregnancy: a new variable predicting severity in haemolytic disease of the fetus and newborn

1 reference

https://api.crossref.org/works/10.1111%2FBJH.14438

21 January 2018

Prophylactic anti-D preparations display variable decreases in Fc-fucosylation of anti-D.

1 reference

https://api.crossref.org/works/10.1111%2FBJH.14438

21 January 2018

Anti-inflammatory activity of IgG1 mediated by Fc galactosylation and association of FcγRIIB and dectin-1.

1 reference

https://api.crossref.org/works/10.1111%2FBJH.14438

21 January 2018

Effect of screening for red cell antibodies, other than anti-D, to detect hemolytic disease of the fetus and newborn: a population study in the Netherlands

1 reference

https://api.crossref.org/works/10.1111%2FBJH.14438

21 January 2018

One single dose of 200 microg of antenatal RhIG halves the risk of anti-D immunization and hemolytic disease of the fetus and newborn in the next pregnancy

1 reference

https://api.crossref.org/works/10.1111%2FBJH.14438

21 January 2018

Risk factors for RhD immunisation despite antenatal and postnatal anti-D prophylaxis

1 reference

https://api.crossref.org/works/10.1111%2FBJH.14438

21 January 2018

Structural basis for improved efficacy of therapeutic antibodies on defucosylation of their Fc glycans

1 reference

https://api.crossref.org/works/10.1111%2FBJH.14438

21 January 2018

Fetal anemia due to non-Rhesus-D red-cell alloimmunization

1 reference

https://api.crossref.org/works/10.1111%2FBJH.14438

21 January 2018

Doppler ultrasonography versus amniocentesis to predict fetal anemia.

1 reference

https://api.crossref.org/works/10.1111%2FBJH.14438

21 January 2018

Applications of Multiple Reaction Monitoring to Clinical Glycomics.

1 reference

https://api.crossref.org/works/10.1111%2FBJH.14438

21 January 2018

Changes in antigen-specific IgG1 Fc N-glycosylation upon influenza and tetanus vaccination

1 reference

https://api.crossref.org/works/10.1111%2FBJH.14438

21 January 2018

The Elements Steering Pathogenesis in IgG-Mediated Alloimmune Diseases

1 reference

https://api.crossref.org/works/10.1111%2FBJH.14438

21 January 2018

Glycosylation pattern of anti-platelet IgG is stable during pregnancy and predicts clinical outcome in alloimmune thrombocytopenia

1 reference

https://api.crossref.org/works/10.1111%2FBJH.14438

21 January 2018

In vitro glycoengineering of IgG1 and its effect on Fc receptor binding and ADCC activity

1 reference

https://api.crossref.org/works/10.1111%2FBJH.14438

21 January 2018

Inhibition of erythroid progenitor cells by anti-Kell antibodies in fetal alloimmune anemia

1 reference

https://api.crossref.org/works/10.1111%2FBJH.14438

21 January 2018

A pilot study showing differences in glycosylation patterns of IgG subclasses induced by pneumococcal, meningococcal, and two types of influenza vaccines.

1 reference

https://api.crossref.org/works/10.1111%2FBJH.14438

21 January 2018

Regulated glycosylation patterns of IgG during alloimmune responses against human platelet antigens

1 reference

https://api.crossref.org/works/10.1111%2FBJH.14438

21 January 2018

The impact of glycosylation on monoclonal antibody conformation and stability

1 reference

https://api.crossref.org/works/10.1111%2FBJH.14438

21 January 2018

Identifiers

10.1111/BJH.14438

1 reference

Europe PubMed Central

PubMed publication ID

27 February 2018

http://europepmc.org/abstract/MED/27891581

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

27 February 2018

http://europepmc.org/abstract/MED/27891581

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q50222648&oldid=1251305121"